The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Isoray
Research Funding - Bioprotect; Bristol-Myers Squibb/Celgene
The impact of TP53 mutations and use of the TP53-mutation-reactivating agent APR-246 on metastatic castrate-sensitive prostate cancer.
 
Tung Hoang
Other Relationship - Vingroup
 
Philip Sutera
Employment - Catalent (I)
Stock and Other Ownership Interests - Catalent (I); Merck; Pfizer
 
Triet Nguyen
No Relationships to Disclose
 
Jin Hee Chang
No Relationships to Disclose
 
Shreya Jagtap
Employment - Nurix
 
Yang Song
No Relationships to Disclose
 
Amol Shetty
No Relationships to Disclose
 
Dipanwita Chowdhury
No Relationships to Disclose
 
Aaron Chan
No Relationships to Disclose
 
Francesca Anna Carrieri
Employment - Lonza
 
Daniel Y. Song
No Relationships to Disclose
 
Theodore L. DeWeese
Stock and Other Ownership Interests - Digital Harmonic
Patents, Royalties, Other Intellectual Property - patent pending on computer algorithm in radiation therapy planning
 
Audrey Lafargue
No Relationships to Disclose
 
Kim Van der Eecken
No Relationships to Disclose
 
Fred Bunz
Expert Testimony - Boehringer Ingelheim
 
Piet Ost
Consulting or Advisory Role - Astellas Pharma; Bayer; Curium Pharma; Janssen-Cilag; Novartis; Telix Pharmaceuticals
Research Funding - Bayer (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Ferring
 
Phuoc T. Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Bayer Health; Dendreon; GenomeDx; Janssen; Myovant Sciences; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical
 
Matthew Deek
No Relationships to Disclose